AAAAAA
Results: 1-25/54
Authors:
BLANN AD
DEROMEUF C
MAZURIER C
MCCOLLUM CN
Citation: Ad. Blann et al., CIRCULATING VON-WILLEBRAND-FACTOR ANTIGEN-II IN ATHEROSCLEROSIS - A COMPARISON WITH VON-WILLEBRAND-FACTOR AND SOLUBLE THROMBOMODULIN, Blood coagulation & fibrinolysis, 9(3), 1998, pp. 261-266
Authors:
GAUCHER C
UNO H
YAMAZAKI T
MASHIBA H
MAZURIER C
Citation: C. Gaucher et al., A NEW CANDIDATE MUTATION (N528S) WITHIN THE VON-WILLEBRAND-FACTOR PROPEPTIDE IDENTIFIED IN A JAPANESE PATIENT WITH PHENOTYPE IIC OF VON-WILLEBRAND-DISEASE, European journal of haematology, 61(2), 1998, pp. 145-148
Authors:
BOWEN DJ
STANDEN GR
MAZURIER C
GAUCHER C
CUMMING A
KEENEY S
BIDWELL J
Citation: Dj. Bowen et al., TYPE 2N VON-WILLEBRAND-DISEASE - RAPID GENETIC DIAGNOSIS OF G2811A (R854Q), C2696T (R816W), T2701A (H817Q) AND G2823T (C858F) - DETECTION OF A NOVEL CANDIDATE TYPE 2N MUTATION - C2810T (R854W), Thrombosis and haemostasis, 80(1), 1998, pp. 32-36
Authors:
DEROMEUF C
MAZURIER C
Citation: C. Deromeuf et C. Mazurier, COMPARISON BETWEEN VON-WILLEBRAND-FACTOR (VWF) AND VWF ANTIGEN-II IN NORMAL INDIVIDUALS AND PATIENTS WITH VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 80(1), 1998, pp. 37-41
Authors:
DEROMEUF C
HILBERT L
MAZURIER C
Citation: C. Deromeuf et al., PLATELET ACTIVATION AND AGGREGATION INDUCED BY RECOMBINANT VON-WILLEBRAND-FACTORS REPRODUCING 4 TYPE 2B VON-WILLEBRAND-DISEASE MISSENSE MUTATIONS, Thrombosis and haemostasis, 79(1), 1998, pp. 211-216
Authors:
CASONATO A
GAUCHER C
PONTARA E
ZUCCHETTO A
ZERBINATI P
MAZURIER C
GIROLAMI A
Citation: A. Casonato et al., TYPE-2N VON-WILLEBRAND-DISEASE DUE TO ARG91GLN SUBSTITUTION AND A CYTOSINE DELETION IN EXON-18 OF THE VON-WILLEBRAND-FACTOR GENE, British Journal of Haematology, 103(1), 1998, pp. 39-41
Authors:
MAZURIER C
RIBBA AS
GAUCHER C
MEYER D
Citation: C. Mazurier et al., MOLECULAR-GENETICS OF VONWILLEBRAND-DISEASE, Annales de genetique, 41(1), 1998, pp. 34-43
Authors:
PITTET JL
BARBALAT V
SANVERT M
VILLARD C
JORIEUX S
MAZURIER C
Citation: Jl. Pittet et al., EVALUATION OF A NEW AUTOMATED ELISA TEST FOR VON-WILLEBRAND-FACTOR USING 2 MONOCLONAL-ANTIBODIES, Blood coagulation & fibrinolysis, 8(4), 1997, pp. 209-215
Authors:
GAUCHER C
MAZURIER C
Citation: C. Gaucher et C. Mazurier, PHENOTYPE IIC VON-WILLEBRAND-DISEASE - IN CIS OR IN TRANS IMPACT OF PROPEPTIDE MUTATIONS ON VON-WILLEBRAND-FACTOR MULTIMERIZATION, Thrombosis and haemostasis, 1997, pp. 1490-1490
Authors:
GAUCHER C
PARQUET A
BAILLOD P
HANSS M
MAZURIER C
Citation: C. Gaucher et al., MUTATIONS LOCALIZED IN THE D3 DOMAIN OF VON-WILLEBRAND-FACTOR ARE IDENTIFIED IN PATIENTS CLASSIFIED IN TYPE-1 OR 2A OF VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 1997, pp. 1583-1583
Authors:
MAZURIER C
UNO H
YAMAZAKI T
GAUCHER C
Citation: C. Mazurier et al., IDENTIFICATION OF A NEW VON-WILLEBRAND-FACTOR PROPEPTIDE MUTATION (N528S) RESPONSIBLE FOR PHENOTYPE IIC VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 1584-1584
Authors:
JORIEUX S
GAUCHER C
FRESSINAUD E
GOUDEMAND J
MEYER D
MAZURIER C
Citation: S. Jorieux et al., MUTATIONS ON CYSTEINE RESIDUE-25 AND RESIDUE-95 OF MATURE VON-WILLEBRAND-FACTOR INDUCE TYPE 2N VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 1586-1586
Authors:
CELIE PHN
DONATH MJSH
JORIEUX S
VANMOURIK JA
MAZURIER C
MERTENS K
Citation: Phn. Celie et al., CHARACTERIZATION OF ARG527 AND ARG531 SUBSTITUTION VARIANTS OF FACTOR-VIII ASSOCIATED WITH MILD HEMOPHILIA-A, Thrombosis and haemostasis, 1997, pp. 2333-2333
Authors:
DEROMEUF C
MAZURIER C
Citation: C. Deromeuf et C. Mazurier, EVIDENCE THAT VON-WILLEBRAND-FACTOR ANTIGEN-II INTERACTS WITH MATURE PLATELET AND PLASMA VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 1997, pp. 2630-2630
Authors:
CULPAN D
STANDEN G
BOWEN D
GOODEVE A
MAZURIER C
GAUCHER C
BIDWELL J
Citation: D. Culpan et al., UHG-BASED MUTATION SCREENING IN TYPE 2A VON-WILLEBRANDS-DISEASE, Thrombosis and haemostasis, 1997, pp. 2664-2664
Authors:
LAVERGNE JM
GU J
JORIEUX S
RASTEGARLARI G
RUAN C
MAZURIER C
MEYER D
Citation: Jm. Lavergne et al., NEW MUTATIONS OF VON-WILLEBRAND-FACTOR (Y271TER AND G785E (GLY22GLU))IN A COMPOUND HETEROZYGOUS PATIENT WITH TYPE 2N VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 2666-2666
Authors:
JORIEUX S
GAUCHER C
PARQUET A
GOUDEMAND J
MAZURIER C
Citation: S. Jorieux et al., A NEW MUTATION, CYS-]ARG AT POSITION-297 OF MATURE VON-WILLEBRAND-FACTOR (VWF), IS IDENTIFIED IN SEVERAL PATIENTS WITH DECREASED FACTOR-VIII BINDING-CAPACITY OF VWF, Thrombosis and haemostasis, 1997, pp. 2668-2668
Authors:
LAVERGNE JM
FRESSINAUD E
GAUCHER C
RIBBA AS
DERLON A
JUHANVAGUE I
GOUDEMAND J
PARQUETGERNEZ A
LELOUCHE F
LEDFORD M
MAZURIER C
MEYER D
Citation: Jm. Lavergne et al., LOCALIZATION IN THE A1 LOOP (AA-509-695) OF VON-WILLEBRAND-FACTOR OF 8 NEW MUTATIONS RESPONSIBLE FOR TYPE 2A OR 2M VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 2669-2669
Authors:
HILBERT L
GAUCHER C
FRESSINAUD E
MEYER D
MAZURIER C
Citation: L. Hilbert et al., A NEW-TYPE 2M (TYPE-B) VWD MUTATION (G1324A) ALSO AT POSITION-561 OF THE MATURE VWF SUBUNIT, Thrombosis and haemostasis, 1997, pp. 2670-2670
Authors:
DEROMEUF C
GAUCHER C
MAZURIER C
Citation: C. Deromeuf et al., PLATELET DISCORDANT TYPE-1 AND TYPE-2 VON-WILLEBRAND-DISEASE MAY RESULT FROM DIMINISHED PLASMA VON-WILLEBRAND-FACTOR DISAPPEARANCE TIME, Thrombosis and haemostasis, 1997, pp. 2681-2681
Authors:
MEYER D
FRESSINAUD E
GAUCHER C
LAVERGNE JM
HILBERT L
RIBBA AS
JORIEUX S
MAZURIER C
Citation: D. Meyer et al., GENE DEFECTS IN 150 UNRELATED FRENCH CASES WITH TYPE-2 VON-WILLEBRAND-DISEASE - FROM THE PATIENT TO THE GENE, Thrombosis and haemostasis, 78(1), 1997, pp. 451-456
Authors:
CULPAN D
STANDEN G
WOOD N
MAZURIER C
GAUCHER C
BIDWELL J
Citation: D. Culpan et al., RAPID MUTATION SCREENING IN TYPE 2A VON WILLEBRANDS DISEASE USING UNIVERSAL HETERODUPLEX GENERATORS, British Journal of Haematology, 96(3), 1997, pp. 464-469
Authors:
MAZURIER C
GAUCHER C
JORIEUX S
PARQUETGERNEZ A
Citation: C. Mazurier et al., MUTATIONS IN THE FVIII GENE IN 7 FAMILIES WITH MILD HEMOPHILIA-A, British Journal of Haematology, 96(2), 1997, pp. 426-427
Authors:
GU J
JORIEUX S
LAVERGNE JM
RUAN C
MAZURIER C
MEYER D
Citation: J. Gu et al., PATIENT WITH TYPE 2N VON-WILLEBRAND-DISEASE IS HETEROZYGOUS FOR A NEWMUTATION - GLY22GLU - DEMONSTRATION OF A DEFECTIVE EXPRESSION OF THE 2ND ALLELE BY THE USE OF MONOCLONAL-ANTIBODIES, Blood, 89(9), 1997, pp. 3263-3269
Authors:
MAZURIER C
MEYER D
Citation: C. Mazurier et D. Meyer, MOLECULAR-BASIS OF VON-WILLEBRAND DISEASE, Bailliere's clinical haematology, 9(2), 1996, pp. 229-241